Published in Cell Res on January 01, 2013
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell (2014) 4.04
Epigenetic reprogramming in cancer. Science (2013) 3.47
Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell (2014) 2.23
Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx. Cell Metab (2017) 1.40
Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep (2014) 1.16
Preclinical studies for induced pluripotent stem cell-based therapeutics. J Biol Chem (2013) 1.00
A Systematic Approach to Identify Candidate Transcription Factors that Control Cell Identity. Stem Cell Reports (2015) 0.95
Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics (2013) 0.94
Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels. Biomaterials (2013) 0.89
Adult Stem Cells and Diseases of Aging. J Clin Med (2014) 0.88
Regeneration versus scarring in vertebrate appendages and heart. J Pathol (2015) 0.86
Activation of aryl hydrocarbon receptor (ahr) by tranilast, an anti-allergy drug, promotes miR-302 expression and cell reprogramming. J Biol Chem (2013) 0.83
Patient-specific induced pluripotent stem cells in neurological disease modeling: the importance of nonhuman primate models. Stem Cells Cloning (2013) 0.83
Models of human core transcriptional regulatory circuitries. Genome Res (2016) 0.83
The potential role of stem cells in the treatment of urinary incontinence. Ther Adv Urol (2015) 0.82
Stem cells and the evolving notion of cellular identity. Philos Trans R Soc Lond B Biol Sci (2015) 0.78
Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming. Ann N Y Acad Sci (2016) 0.77
Reprogramming cell fate: a changing story. Front Cell Dev Biol (2014) 0.77
Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells. PLoS One (2014) 0.77
Regeneration through Reprogramming Adult Cell Identity in Vivo. Am J Pathol (2015) 0.76
MicroRNA-dependent genetic networks during neural development. Cell Tissue Res (2014) 0.76
Grand challenges in the field of stem cell research. Front Cell Dev Biol (2014) 0.76
The ups and downs of somatic cell nucleus transfer (SCNT) in humans. J Assist Reprod Genet (2013) 0.76
Reversible mitochondrial DNA accumulation in nuclei of pluripotent stem cells. Stem Cells Dev (2014) 0.76
Pluripotent stem cells from maturing oocytes. Cell Reprogram (2013) 0.75
Development of regional specificity of spinal and medullary dorsal horn neurons. World J Biol Chem (2016) 0.75
Sanofi-Cell Research Outstanding Paper Award of 2013. Cell Res (2014) 0.75
Large-scale mapping of mammalian transcriptomes identifies conserved genes associated with different cell states. Nucleic Acids Res (2016) 0.75
Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker. Oncotarget (2016) 0.75
Direct lineage reprogramming via pioneer factors; a detour through developmental gene regulatory networks. Development (2016) 0.75
Asymmetric Regulation of Peripheral Genes by Two Transcriptional Regulatory Networks. PLoS One (2016) 0.75
A Blueprint for a Synthetic Genetic Feedback Controller to Reprogram Cell Fate. Cell Syst (2017) 0.75
Model-based transcriptome engineering promotes a fermentative transcriptional state in yeast. Proc Natl Acad Sci U S A (2016) 0.75
FOXA and master transcription factors recruit Mediator and Cohesin to the core transcriptional regulatory circuitry of cancer cells. Sci Rep (2016) 0.75
A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue. Nat Commun (2017) 0.75
Transcriptional Addiction in Cancer. Cell (2017) 0.75
Tuning cell fate: from insights to vertebrate regeneration. Organogenesis (2014) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 22.17
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 18.96
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47
In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Nanog safeguards pluripotency and mediates germline development. Nature (2007) 13.01
Chromatin signatures of pluripotent cell lines. Nat Cell Biol (2006) 12.88
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development (2002) 12.21
Hematopoiesis: an evolving paradigm for stem cell biology. Cell (2008) 11.95
Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol (2006) 10.95
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol (2008) 10.63
Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol (2008) 10.60
Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature (1991) 10.30
Insulin-promoter-factor 1 is required for pancreas development in mice. Nature (1994) 10.13
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol (2010) 9.24
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 9.04
Direct cell reprogramming is a stochastic process amenable to acceleration. Nature (2009) 8.71
c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell (2007) 8.46
Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature (1998) 8.42
Sheep cloned by nuclear transfer from a cultured cell line. Nature (1996) 7.86
Stepwise reprogramming of B cells into macrophages. Cell (2004) 7.68
Gene regulatory networks in the evolution and development of the heart. Science (2006) 7.67
Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell (2010) 7.51
Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A (1989) 7.19
Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature (2008) 7.07
Induction of human neuronal cells by defined transcription factors. Nature (2011) 6.84
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell (2011) 6.71
Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell (1979) 6.47
Gene regulatory networks and the evolution of animal body plans. Science (2006) 6.42
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature (2011) 6.21
Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol (2008) 6.19
Plasticity of the differentiated state. Science (1985) 6.19
Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science (2005) 6.14
Pioneer transcription factors: establishing competence for gene expression. Genes Dev (2011) 6.01
Forcing cells to change lineages. Nature (2009) 5.99
A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell (2008) 5.99
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature (2011) 5.84
Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell (1983) 5.71
MicroRNA-mediated conversion of human fibroblasts to neurons. Nature (2011) 5.59
Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol (2001) 5.42
Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature (2007) 5.39
Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35
Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature (2011) 5.28
beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev (1998) 5.25
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
Retracted Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. Cell (2011) 5.09
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Epigenetic reprogramming and induced pluripotency. Development (2009) 4.90
Making or breaking the heart: from lineage determination to morphogenesis. Cell (2006) 4.85
Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A (2011) 4.81
Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell (2011) 4.65
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol (2011) 4.64
A molecular roadmap of reprogramming somatic cells into iPS cells. Cell (2012) 4.41
Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs. Proc Natl Acad Sci U S A (1952) 4.32
Generation and regeneration of cells of the liver and pancreas. Science (2008) 4.21
Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A (2008) 4.20
Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature (2002) 4.16
Human oocytes reprogram somatic cells to a pluripotent state. Nature (2011) 4.03
Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 3.96
Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A (2011) 3.93
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev (1995) 3.83
Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell (2012) 3.80
Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Nat Cell Biol (2007) 3.71
Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell (2011) 3.62
Reactivation of the paternal X chromosome in early mouse embryos. Science (2004) 3.59
Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev (2002) 3.52
Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell (2012) 3.52
Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci U S A (2012) 3.52
PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci U S A (2008) 3.35
NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med (2003) 3.26
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol (2011) 3.25
Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature (1958) 3.16
Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology (2010) 3.16
Mediators of reprogramming: transcription factors and transitions through mitosis. Nat Rev Mol Cell Biol (2008) 3.12
Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells (2008) 2.93
MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol (2005) 2.85
The determination of projection neuron identity in the developing cerebral cortex. Curr Opin Neurobiol (2008) 2.77
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development (2000) 2.73
PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev (1998) 2.69
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol (2010) 2.60
Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity (2006) 2.58
Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell (2011) 2.49
Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J Neurosci (2007) 2.27
Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors. Neuron (2001) 2.22
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Selective blockade of microRNA processing by Lin28. Science (2008) 14.39
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol (2009) 11.18
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet (2009) 10.54
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell (2009) 8.97
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell (2005) 7.99
Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol (2009) 7.59
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature (2007) 7.55
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature (2011) 7.43
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell (2011) 7.41
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol (2009) 6.76
Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet (2009) 6.35
Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature (2010) 6.06
HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell (2002) 5.71
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell (2003) 5.71
Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet (2010) 5.37
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Generation of induced pluripotent stem cells from human blood. Blood (2009) 4.92
Generation of human-induced pluripotent stem cells. Nat Protoc (2008) 4.85
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell (2009) 4.69
The Lin28/let-7 axis regulates glucose metabolism. Cell (2011) 4.65
Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature (2003) 4.56
Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell (2002) 4.56
Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J Biol Chem (2008) 4.40
Chromatin-modifying enzymes as modulators of reprogramming. Nature (2012) 4.22
Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature (2009) 4.14
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature (2009) 3.93
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature (2010) 3.39
Lin28: A microRNA regulator with a macro role. Cell (2010) 3.39
Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology (2010) 3.36
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol (2011) 3.25
Activation of tyrosine kinases by mutation of the gatekeeper threonine. Nat Struct Mol Biol (2008) 3.18
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell (2013) 3.08
Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell (2009) 3.03
Biomechanical forces promote embryonic haematopoiesis. Nature (2009) 2.99
Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science (2012) 2.98
Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival. Cell (2011) 2.98
Reprogramming of T cells from human peripheral blood. Cell Stem Cell (2010) 2.93
A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature (2009) 2.88
Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One (2011) 2.86
Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development (2011) 2.82
A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells. PLoS Genet (2009) 2.78
High-efficiency RNA interference in human embryonic stem cells. Stem Cells (2005) 2.76
Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies. Nat Genet (2010) 2.72
Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat Cell Biol (2011) 2.65
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (2009) 2.59
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell (2007) 2.56
Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell (2011) 2.53
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med (2010) 2.50
LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells (2004) 2.37
Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature (2010) 2.36
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci U S A (2005) 2.28
Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell (2013) 2.27
BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell (2008) 2.17
cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes. Nature (2003) 2.16
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A (2012) 2.14
Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell (2007) 2.14
Overcoming reprogramming resistance of Fanconi anemia cells. Blood (2012) 2.07
Polycomb repressive complex 2 regulates normal development of the mouse heart. Circ Res (2011) 2.05
Stem cell metabolism in tissue development and aging. Development (2013) 2.01
The transcriptional landscape of hematopoietic stem cell ontogeny. Cell Stem Cell (2012) 1.96
Therapeutic potential of embryonic stem cells. Blood Rev (2005) 1.96
Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol (2013) 1.91
Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell (2012) 1.89
Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood (2010) 1.88
Lin28 sustains early renal progenitors and induces Wilms tumor. Genes Dev (2014) 1.87
Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems. Biotechnol Bioeng (2002) 1.85
Mechanisms and implications of imatinib resistance mutations in BCR-ABL. Curr Opin Hematol (2004) 1.83
Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev (2010) 1.77
Altered nuclear transfer in stem-cell research - a flawed proposal. N Engl J Med (2004) 1.77
Upping the ante: recent advances in direct reprogramming. Mol Ther (2009) 1.73
Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336. Blood (2002) 1.72
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann Neurol (2011) 1.72
Reprogramming cellular identity for regenerative medicine. Cell (2012) 1.71
Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes. Blood (2008) 1.71
Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell (2013) 1.68
A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. Genes Dev (2002) 1.65
Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol (2010) 1.65
Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res (2012) 1.65
The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood (2007) 1.64
Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci U S A (2012) 1.62
Human embryonic stem cell derivation from poor-quality embryos. Nat Biotechnol (2008) 1.60
Novel role for PDEF in epithelial cell migration and invasion. Cancer Res (2005) 1.57
Investigating monogenic and complex diseases with pluripotent stem cells. Nat Rev Genet (2011) 1.55
Bayesian analysis of signaling networks governing embryonic stem cell fate decisions. Bioinformatics (2004) 1.52
Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells. Blood (2009) 1.51
Novel retroviral vectors to facilitate expression screens in mammalian cells. Nucleic Acids Res (2002) 1.51
MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell (2010) 1.49
Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med (2013) 1.45
Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5. Proc Natl Acad Sci U S A (2003) 1.40
Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos. Nat Genet (2008) 1.39